These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 16237069)

  • 1. Differential effects of B and T lymphocyte attenuator and programmed death-1 on acceptance of partially versus fully MHC-mismatched cardiac allografts.
    Tao R; Wang L; Han R; Wang T; Ye Q; Honjo T; Murphy TL; Murphy KM; Hancock WW
    J Immunol; 2005 Nov; 175(9):5774-82. PubMed ID: 16237069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Critical role of donor tissue expression of programmed death ligand-1 in regulating cardiac allograft rejection and vasculopathy.
    Yang J; Popoola J; Khandwala S; Vadivel N; Vanguri V; Yuan X; Dada S; Guleria I; Tian C; Ansari MJ; Shin T; Yagita H; Azuma M; Sayegh MH; Chandraker A
    Circulation; 2008 Feb; 117(5):660-9. PubMed ID: 18212277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. B and T lymphocyte attenuator mediates inhibition of tumor-reactive CD8+ T cells in patients after allogeneic stem cell transplantation.
    Hobo W; Norde WJ; Schaap N; Fredrix H; Maas F; Schellens K; Falkenburg JH; Korman AJ; Olive D; van der Voort R; Dolstra H
    J Immunol; 2012 Jul; 189(1):39-49. PubMed ID: 22634623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined coinhibitory and costimulatory modulation with anti-BTLA and CTLA4Ig facilitates tolerance in murine islet allografts.
    Truong W; Plester JC; Hancock WW; Merani S; Murphy TL; Murphy KM; Kaye J; Anderson CC; Shapiro AM
    Am J Transplant; 2007 Dec; 7(12):2663-74. PubMed ID: 17983390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T follicular helper expansion and humoral-mediated rejection are independent of the HVEM/BTLA pathway.
    Rodriguez-Barbosa JI; Fernandez-Renedo C; Moral AMB; Bühler L; Del Rio ML
    Cell Mol Immunol; 2017 Jun; 14(6):497-510. PubMed ID: 26924526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blocking the monocyte chemoattractant protein-1/CCR2 chemokine pathway induces permanent survival of islet allografts through a programmed death-1 ligand-1-dependent mechanism.
    Lee I; Wang L; Wells AD; Ye Q; Han R; Dorf ME; Kuziel WA; Rollins BJ; Chen L; Hancock WW
    J Immunol; 2003 Dec; 171(12):6929-35. PubMed ID: 14662900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MHC-mismatched chimerism is required for induction of transplantation tolerance in autoimmune nonobese diabetic recipients.
    Wang M; Racine J; Zhang M; Wu T; Deng R; Johnston H; Shen C; Siswanto K; Zeng D
    J Immunol; 2014 Aug; 193(4):2005-15. PubMed ID: 25000982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CCR5 is required for regulation of alloreactive T-cell responses to single class II MHC-mismatched murine cardiac grafts.
    Nozaki T; Rosenblum JM; Schenk AD; Ishii D; Fairchild RL
    Am J Transplant; 2009 Oct; 9(10):2251-61. PubMed ID: 19656127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of MHC and non-MHC genes on the nature of murine cardiac allograft rejection. I. Kinetic analysis of mononuclear cell infiltrate and MHC-class I/class II expression in donor tissue.
    Wang YC; Mayne A; Sell KW; Ahmed-Ansari A
    Transplantation; 1990 Aug; 50(2):313-24. PubMed ID: 2200176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PD-L1/PD-1 signal deficiency promotes allogeneic immune responses and accelerates heart allograft rejection.
    Wang W; Carper K; Malone F; Latchman Y; Perkins J; Fu Y; Reyes J; Li W
    Transplantation; 2008 Sep; 86(6):836-44. PubMed ID: 18813109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MHC-mismatched islet allografts are vulnerable to autoimmune recognition in vivo.
    Kupfer TM; Crawford ML; Pham K; Gill RG
    J Immunol; 2005 Aug; 175(4):2309-16. PubMed ID: 16081800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD8+ lymphocytes augment chronic rejection in a MHC class II mismatched model.
    Fischbein MP; Yun J; Laks H; Irie Y; Fishbein MC; Espejo M; Bonavida B; Ardehali A
    Transplantation; 2001 Apr; 71(8):1146-53. PubMed ID: 11374417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Permanent survival of fully MHC-mismatched islet allografts by targeting a single chemokine receptor pathway.
    Wang L; Han R; Lee I; Hancock AS; Xiong G; Gunn MD; Hancock WW
    J Immunol; 2005 Nov; 175(10):6311-8. PubMed ID: 16272282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BTLA mediates inhibition of human tumor-specific CD8+ T cells that can be partially reversed by vaccination.
    Derré L; Rivals JP; Jandus C; Pastor S; Rimoldi D; Romero P; Michielin O; Olive D; Speiser DE
    J Clin Invest; 2010 Jan; 120(1):157-67. PubMed ID: 20038811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An agonistic anti-BTLA mAb (3C10) induced generation of IL-10-dependent regulatory CD4+ T cells and prolongation of murine cardiac allograft.
    Uchiyama M; Jin X; Matsuda H; Bashuda H; Imazuru T; Shimokawa T; Yagita H; Niimi M
    Transplantation; 2014 Feb; 97(3):301-9. PubMed ID: 24448587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. B and T lymphocyte attenuator is highly expressed on CMV-specific T cells during infection and regulates their function.
    Serriari NE; Gondois-Rey F; Guillaume Y; Remmerswaal EB; Pastor S; Messal N; Truneh A; Hirsch I; van Lier RA; Olive D
    J Immunol; 2010 Sep; 185(6):3140-8. PubMed ID: 20693422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Programmed cell death 1 (PD-1) and its ligand PD-L1 are required for allograft tolerance.
    Wang L; Han R; Hancock WW
    Eur J Immunol; 2007 Oct; 37(10):2983-90. PubMed ID: 17899549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD4 T cell-mediated cardiac allograft rejection requires donor but not host MHC class II.
    Pietra BA; Wiseman A; Bolwerk A; Rizeq M; Gill RG
    J Clin Invest; 2000 Oct; 106(8):1003-10. PubMed ID: 11032860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Programmed death-1 targeting can promote allograft survival.
    Ozkaynak E; Wang L; Goodearl A; McDonald K; Qin S; O'Keefe T; Duong T; Smith T; Gutierrez-Ramos JC; Rottman JB; Coyle AJ; Hancock WW
    J Immunol; 2002 Dec; 169(11):6546-53. PubMed ID: 12444166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A coreceptor interaction between the CD28 and TNF receptor family members B and T lymphocyte attenuator and herpesvirus entry mediator.
    Gonzalez LC; Loyet KM; Calemine-Fenaux J; Chauhan V; Wranik B; Ouyang W; Eaton DL
    Proc Natl Acad Sci U S A; 2005 Jan; 102(4):1116-21. PubMed ID: 15647361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.